The Emerging Role of Epitranscriptomics in Cancer: Focus on Urological TumorsJoão Lobo, Cármen Jerónimo, Daniela Barros‐Silva et al.|Genes|2018Cited by 87
VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate CancerDaniela Barros‐Silva, Cármen Jerónimo, João Lobo et al.|Cancers|2020Cited by 85
Germ cell tumour subtypes display differential expression of microRNA371a-3pBárbara Vilela-Salgueiro, Cármen Jerónimo, Daniela Barros‐Silva et al.|Philosophical Transactions of the Royal Society B Biological Sciences|2018Cited by 63
The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumorsVera Miranda‐Gonçalves, Cármen Jerónimo, João Lobo et al.|Journal of Experimental & Clinical Cancer Research|2021Cited by 59
Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signalingCatarina Macedo‐Silva, Cármen Jerónimo, Daniela Barros‐Silva et al.|Signal Transduction and Targeted Therapy|2023Cited by 50